Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AOXING PHARMACEUTICAL COMPANY, INC.Financial_Report.xls
10-Q/A - AOXING PHARMACEUTICAL COMPANY, INC 10QA1 2011-12-31 - AOXING PHARMACEUTICAL COMPANY, INC.aoxingpharma10qa1.htm
EX-31.1 - RULE 13A-14(A) CERTIFICATION ? CEO - AOXING PHARMACEUTICAL COMPANY, INC.aoxingpharmaexh311.htm
EX-31.2 - RULE 13A-14(A) CERTIFICATION ? CFO - AOXING PHARMACEUTICAL COMPANY, INC.aoxingpharmaexh312.htm


EXHIBIT 32: Rule 13a-14(b) Certification

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Aoxing Pharmaceutical Company, Inc. (the “Company”) certify that:
 
1. The Quarterly Report on Form 10-Q/A of the Company for the period ended December 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

September 28, 2012
/s/ Zhenjiang Yue
 
Zhenjiang Yue, Chief Executive Officer
 
 
September 28, 2012
/s/ Guoan Zhang
 
Guoan Zhang, Chief Financial Officer